Sibyane Stillwater (SBSW) PT Raised to $28 at RBC Capital
- Tech stocks push S&P 500 to record close, buoy Nasdaq
- U.S. Calls for Pause of J&J (JNJ) Vaccine After Clotting Cases, Including One Death
- Coinbase (COIN) direct listing IPO reference price set at $250
- Biggest SPAC Deal Ever: Grab To Go Public in a $40 Billion Merger With Altimeter (AGC), Backed by Fidelity and BlackRock
- Oil rises after robust China data but J&J vaccine pause weighs
RBC Capital analyst Tyler Broda raised the price target on Sibyane Stillwater (NYSE: SBSW) to $28.00 (from $25.00) while maintaining a Outperform rating.
You May Also Be Interested In
- UPDATE: JPMorgan Upgrades Spirit Airlines (SAVE) to Overweight
- CIBC Downgrades OrganiGram Holdings Inc. (OGI:CN) (OGRMF) to Underperformer
- Stabilus SA (STM:GR) PT Raised to EUR77 at Berenberg
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!